Effer-K 25meq Effervesc Tabs Orange

Manufacturer NOMAX INC Active Ingredient Potassium Bicarbonate and Potassium Citrate(poe TASS ee um bye KAR bun ate & poe TASS ee um SIT rate) Pronunciation poe TASS ee um bye KAR bun ate & poe TASS ee um SIT rate
It is used to treat or prevent low potassium levels.
đŸˇī¸
Drug Class
Electrolyte supplement; Urinary alkalinizer
đŸ§Ŧ
Pharmacologic Class
Potassium salt; Citrate salt
🤰
Pregnancy Category
C
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is a potassium supplement that also helps make your urine less acidic. It's used to treat low potassium levels and to prevent certain types of kidney stones, like those made of calcium oxalate or uric acid.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your dose during or after meals. If you're using flavored tablets, dissolve them in at least 4 ounces (120 mL) of cold or ice water. For unflavored tablets, use at least 4 ounces (120 mL) of cold fruit juice. Do not swallow the tablet whole; make sure it's fully dissolved before swallowing. If you're unsure about preparing your dose, consult your doctor. Drink the mixture slowly and do not save it for later use.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, avoiding bathrooms. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposal, consult your pharmacist. You may also have access to drug take-back programs in your area.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Always dissolve the tablet completely in 3-4 ounces (about half a glass) of cold water before drinking. Do not chew or swallow the tablet whole.
  • Take this medication with food or immediately after meals to reduce stomach upset.
  • Do not use salt substitutes or other potassium supplements unless directed by your doctor.
  • Report any signs of muscle weakness, tingling, or a slow/irregular heartbeat to your doctor immediately.
  • Maintain adequate fluid intake throughout the day, especially when taking this medication for kidney stone prevention.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 25 mEq (1 tablet) dissolved in 3-4 oz of cold water, 2 to 4 times daily, or as directed by physician.
Dose Range: 50 - 100 mg

Condition-Specific Dosing:

Hypokalemia: 50-100 mEq/day in divided doses, adjusted based on serum potassium levels.
Renal Tubular Acidosis (RTA): 50-100 mEq/day in divided doses, adjusted to maintain normal serum bicarbonate and urinary pH.
Uric Acid Lithiasis: 50-100 mEq/day in divided doses, adjusted to maintain urinary pH between 6.0 and 7.0.
Calcium Oxalate Lithiasis with Hypocitraturia: 50-100 mEq/day in divided doses, adjusted to maintain urinary citrate excretion > 320 mg/day and urinary pH between 6.0 and 7.0.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established (Use with extreme caution, dose based on weight and specific condition, e.g., RTA)
Child: Not established (Use with caution, dose based on weight and specific condition, e.g., RTA, typically 1-3 mEq/kg/day in divided doses)
Adolescent: Dosing similar to adult for specific indications, but with careful monitoring and consideration of body weight.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution; monitor serum potassium and renal function closely.
Moderate: Contraindicated in patients with severe renal impairment (GFR < 30 mL/min/1.73 m2). Use with extreme caution and reduced dosage in moderate impairment (GFR 30-60 mL/min/1.73 m2) with frequent potassium monitoring.
Severe: Contraindicated due to high risk of hyperkalemia.
Dialysis: Contraindicated due to high risk of hyperkalemia.

Hepatic Impairment:

Mild: No specific adjustment needed, but monitor electrolytes if underlying conditions predispose to imbalance.
Moderate: No specific adjustment needed, but monitor electrolytes if underlying conditions predispose to imbalance.
Severe: No specific adjustment needed, but monitor electrolytes if underlying conditions predispose to imbalance.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Potassium bicarbonate and potassium citrate provide potassium, an essential intracellular cation, to correct hypokalemia. The citrate component is metabolized in the liver to bicarbonate, which acts as an alkalinizing agent. This increases urinary pH and urinary citrate excretion, thereby inhibiting the crystallization of calcium oxalate and uric acid, which are common components of kidney stones.
📊

Pharmacokinetics

Absorption:

Bioavailability: High (well absorbed from the GI tract)
Tmax: Approximately 1-1.5 hours for potassium, but sustained release of bicarbonate effect.
FoodEffect: Absorption is not significantly affected by food, but taking with food or after meals is recommended to minimize gastrointestinal irritation.

Distribution:

Vd: Potassium is widely distributed throughout the body, primarily intracellularly. Citrate is also widely distributed.
ProteinBinding: Potassium is not protein bound. Citrate is minimally protein bound.
CnssPenetration: Limited

Elimination:

HalfLife: Not applicable for potassium itself (homeostatically regulated). The alkalinizing effect of citrate lasts several hours.
Clearance: Primarily renal for potassium. Citrate is metabolized and then excreted renally as bicarbonate.
ExcretionRoute: Renal (potassium, bicarbonate)
Unchanged: Less than 5% of citrate is excreted unchanged in urine; the majority is metabolized.
âąī¸

Pharmacodynamics

OnsetOfAction: Within 1-2 hours for initial electrolyte correction and urinary alkalinization.
PeakEffect: Approximately 2-4 hours for urinary pH and citrate excretion.
DurationOfAction: Approximately 4-6 hours for urinary alkalinization.

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high potassium levels, including:
+ Abnormal heartbeat
+ Confusion
+ Weakness, lightheadedness, or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Vomiting blood or coffee ground-like material
Black, tarry, or bloody stools

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms, contact your doctor for advice:

Diarrhea
Stomach pain
Upset stomach
Vomiting
* Gas

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe muscle weakness or paralysis
  • Numbness or tingling in hands or feet
  • Slow, irregular, or pounding heartbeat
  • Unusual fatigue or confusion
  • Black, tarry, or bloody stools (signs of gastrointestinal bleeding)
  • Severe stomach pain or vomiting
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have high potassium levels, as this may affect the safety of taking this medication.
If you are currently taking any of the following medications: Amiloride, Eplerenone, Spironolactone, or Triamterene, as these may interact with this drug.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to disclose all of your:

Prescription and over-the-counter (OTC) medications
Natural products
Vitamins
* Health problems

Your doctor and pharmacist need this information to assess the safety of taking this medication with your other treatments and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor to confirm it is safe to do so.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood work and laboratory tests, as directed by your doctor, are crucial to monitor your condition. Prior to initiating this medication and during treatment, your doctor may recommend an electrocardiogram (ECG) to assess your heart's electrical activity. Adhere strictly to the prescribed dosage, as exceeding the recommended amount may increase the risk of severe side effects. If you follow a low-sodium diet or use salt substitutes, consult your doctor to discuss potential interactions. Additionally, if you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor to weigh the benefits and risks of this medication to both you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Hyperkalemia (high potassium levels): muscle weakness, flaccid paralysis, paresthesias, mental confusion, fatigue, bradycardia, hypotension, cardiac arrhythmias (including ventricular fibrillation and asystole).

What to Do:

Seek immediate medical attention. Management includes discontinuing potassium, administering calcium gluconate (for cardiac stability), insulin and glucose, sodium bicarbonate, loop diuretics, and potentially dialysis in severe cases. Call 1-800-222-1222 (Poison Control).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
  • ACE inhibitors (e.g., lisinopril, enalapril)
  • Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan)
🔴

Major Interactions

  • NSAIDs (e.g., ibuprofen, naproxen) - may increase risk of hyperkalemia and renal dysfunction.
  • Digoxin - hyperkalemia can worsen digoxin toxicity; hypokalemia can precipitate digoxin toxicity.
  • Salt substitutes containing potassium - additive hyperkalemia risk.
🟡

Moderate Interactions

  • Anticholinergics (e.g., atropine, dicyclomine) - may slow GI transit, increasing risk of GI irritation/ulceration from potassium salts.
  • Other potassium-containing medications or supplements.
đŸŸĸ

Minor Interactions

  • None specifically noted for significant clinical impact.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Potassium

Rationale: To establish baseline and identify pre-existing hyperkalemia or severe hypokalemia requiring immediate attention.

Timing: Prior to initiation of therapy.

Renal Function (BUN, Serum Creatinine, GFR)

Rationale: To assess kidney function, as impaired renal function significantly increases the risk of hyperkalemia.

Timing: Prior to initiation of therapy.

Electrocardiogram (ECG)

Rationale: Recommended in patients with pre-existing cardiac disease or significant electrolyte abnormalities, as hyperkalemia can cause life-threatening arrhythmias.

Timing: Prior to initiation, if indicated.

📊

Routine Monitoring

Serum Potassium

Frequency: Periodically (e.g., weekly initially, then monthly to quarterly, or as clinically indicated)

Target: 3.5-5.0 mEq/L

Action Threshold: If > 5.0 mEq/L, reduce dose or discontinue; if > 5.5 mEq/L, discontinue and manage hyperkalemia; if < 3.5 mEq/L, consider dose increase.

Renal Function (BUN, Serum Creatinine)

Frequency: Periodically (e.g., every 3-6 months, or more frequently if renal function is unstable or interacting drugs are used)

Target: Within normal limits for patient's age/sex

Action Threshold: Significant decline in GFR or rise in creatinine warrants dose reduction or discontinuation and re-evaluation.

Urinary pH (for stone prevention)

Frequency: Daily or several times a week initially, then periodically (e.g., weekly to monthly)

Target: 6.0-7.0

Action Threshold: If consistently < 6.0, consider dose increase; if consistently > 7.0, consider dose reduction.

24-hour Urinary Citrate (for stone prevention)

Frequency: Periodically (e.g., every 3-6 months after stabilization)

Target: > 320 mg/day

Action Threshold: If < 320 mg/day, consider dose increase.

đŸ‘ī¸

Symptom Monitoring

  • Signs of hyperkalemia: unusual fatigue, muscle weakness, flaccid paralysis, paresthesias (tingling/numbness), bradycardia, irregular heartbeat.
  • Gastrointestinal symptoms: nausea, vomiting, diarrhea, abdominal discomfort, black/tarry stools (indicating GI bleeding).

Special Patient Groups

🤰

Pregnancy

Potassium is an essential electrolyte. While generally considered safe if maternal potassium levels are carefully monitored, high doses or pre-existing renal impairment could lead to hyperkalemia, which may affect the fetus. Use only if clearly needed and the benefit outweighs the potential risk, with close monitoring of maternal electrolytes.

Trimester-Specific Risks:

First Trimester: No specific data suggesting increased risk of congenital malformations.
Second Trimester: Risk of hyperkalemia if not monitored.
Third Trimester: Risk of hyperkalemia if not monitored; potential for effects on fetal heart rate if severe maternal hyperkalemia occurs.
🤱

Lactation

Potassium is naturally present in breast milk. While generally considered compatible with breastfeeding, caution is advised. Monitor the infant for signs of hyperkalemia (e.g., lethargy, poor feeding, arrhythmias) if the maternal dose is high or if the infant has impaired renal function.

Infant Risk: Low risk with appropriate maternal dosing and monitoring; potential for hyperkalemia in the infant if maternal dose is excessive or infant has renal impairment.
đŸ‘ļ

Pediatric Use

Use with extreme caution. Dosing must be individualized based on weight, serum potassium levels, and underlying condition (e.g., RTA). Risk of hyperkalemia is higher in children, especially those with renal impairment. Close monitoring of serum potassium and renal function is essential.

👴

Geriatric Use

Geriatric patients are at increased risk for renal impairment, which significantly increases the risk of hyperkalemia. They may also be on multiple medications that interact with potassium (e.g., ACE inhibitors, ARBs, NSAIDs). Close monitoring of serum potassium and renal function is crucial. Start with lower doses and titrate carefully.

Clinical Information

💎

Clinical Pearls

  • Always ensure the effervescent tablet is fully dissolved in water before administration to prevent localized high concentrations of potassium in the GI tract, which can lead to irritation or ulceration.
  • Instruct patients to take the medication with or immediately after meals to minimize gastrointestinal upset.
  • Emphasize the importance of regular blood tests (serum potassium, renal function) as directed by the physician, especially when initiating therapy, changing doses, or if symptoms of hyperkalemia develop.
  • Advise patients to avoid salt substitutes, low-sodium foods that contain potassium, and other potassium supplements unless specifically approved by their healthcare provider.
  • For kidney stone prevention, consistent adherence to the dosing regimen and monitoring of urinary pH are key to therapeutic success.
🔄

Alternative Therapies

  • Potassium Chloride (for hypokalemia without acidosis or hypocitraturia)
  • Potassium Gluconate (oral potassium supplement)
  • Sodium Bicarbonate (for metabolic acidosis, but does not provide potassium)
  • Sodium Citrate/Citric Acid (e.g., Bicitra, for urinary alkalinization, but does not provide potassium)
  • Potassium Citrate (e.g., Urocit-K, for hypocitraturia and stone prevention, but may not contain bicarbonate component)
💰

Cost & Coverage

Average Cost: $30 - $80 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (preferred generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.